Lexicon Pharmaceuticals (LXRX) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Lexicon Pharmaceuticals (LXRX) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
-14.40% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
3.41% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
13.10% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Lexicon Pharmaceuticals |
750.45 Mn |
579.79 Mn |
20.99 Mn |
-7.39% |
| Date | Value |
|---|
| Mar 31, 2026 |
-7.39% |
| Dec 31, 2025 |
-3.47% |
| Sep 30, 2025 |
28.57% |
| Jun 30, 2025 |
27.24% |
| Mar 31, 2025 |
26.43% |
| Dec 31, 2024 |
28.31% |
| Sep 30, 2024 |
17.65% |
| Jun 30, 2024 |
17.61% |
| Mar 31, 2024 |
83.97% |
| Dec 31, 2023 |
88.85% |
| Sep 30, 2023 |
-42.30% |
| Jun 30, 2023 |
-42.40% |
| Mar 31, 2023 |
-45.43% |
| Dec 31, 2022 |
-47.17% |
| Sep 30, 2022 |
-59.98% |
| Jun 30, 2022 |
-58.99% |
| Mar 31, 2022 |
-58.06% |
| Dec 31, 2021 |
-57.99% |
| Sep 30, 2021 |
-56.83% |
| Jun 30, 2021 |
-58.47% |
